Literature DB >> 18581067

Prospective study of children with Guillain-Barre syndrome.

Roshan Lal Koul1, Amna Alfutaisi.   

Abstract

OBJECTIVES: To see the pattern, and outcome of Guillain Barre syndrome in this country.
METHODS: All the children under fifteen years with final diagnosis of Guillain-Barre syndrome formed the subjects of the study. All children with acute flaccid paralysis were investigated for the underlying cause. The diagnosis of Gullain-Barre syndrome was made on clinical criteria, cerebrospinal findings and the nerve conduction studies. Intravenous immunoglobulins were given to all and only two children needed plasmapharesis. RESULT: Fifty-two children were seen and constituted 20% of total acute flaccid paralysis cases. Cranial nerves were involved in fifty percent children. Albuminocytological dissociation in cerebrospinal fluid was seen in 97.5 percent cases. Acute relapse was seen in 11.5%. Seventeen percent required ventilation. The complete recovery was seen in 45 to 282 days (mean 68 days). Three children (5.8%) were left with minimal residual defecit. There was no mortality.
CONCLUSION: The Guillain-Barre syndrome, though is a serious disease, recovery is the rule in children. Very low mortality and morbidity is seen. Immunoglobulins have reduced the length of hospital stay and also reduced the total time for recovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581067     DOI: 10.1007/s12098-008-0099-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

Review 1.  Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  R A Hughes
Journal:  Ther Apher       Date:  1997-05

2.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

3.  Immune globulins are effective in severe pediatric Guillain-Barré syndrome.

Authors:  E Shahar; Z Shorer; C M Roifman; Y Levi; N Brand; S Ravid; E G Murphy
Journal:  Pediatr Neurol       Date:  1997-01       Impact factor: 3.372

Review 4.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

5.  Recurrent Guillain Barre' Syndrome: a clinical, electrophysiological and morphological study.

Authors:  A B Taly; S K Gupta; V Anisya; S K Shankar; S Rao; K B Das; D Nagaraja; H S Swamy
Journal:  J Assoc Physicians India       Date:  1995-04

6.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

7.  Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment.

Authors:  L H Castro; A H Ropper
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

8.  Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.

Authors:  H Rantala; J D Cherry; W D Shields; M Uhari
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

9.  Childhood Guillain-Barré syndrome in Paraguay, 1990 to 1991.

Authors:  D E Hart; L A Rojas; J A Rosário; H Recalde; G C Román
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

10.  Recurrent Guillain-Barré syndrome in Japan.

Authors:  M Baba; M Matsunaga; S Narita; H Liu
Journal:  Intern Med       Date:  1995-10       Impact factor: 1.271

View more
  5 in total

1.  A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.

Authors:  Khaled Saad; Ismail L Mohamad; Mohamed A Abd El-Hamed; Mostafa S K Tawfeek; Ahmed E Ahmed; Khaled A Abdel Baseer; Ahmed S El-Shemy; Amira A El-Houfey; Diaa M Tamer
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

2.  Clinical features and prognosis with Guillain-Barré syndrome.

Authors:  Sinan Akbayram; Murat Doğan; Cihangir Akgün; Erdal Peker; Refah Sayιn; Fesih Aktar; Mehmet-Selçuk Bektaş; Hüseyin Caksen
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

3.  Electrophysiological Subtypes and Prognostic Factors of Childhood Guillain-Barré Syndrome.

Authors:  Bahadır Konuşkan; Çetin Okuyaz; Bahar Taşdelen; Semra Hiz Kurul; Banu Anlar
Journal:  Noro Psikiyatr Ars       Date:  2018-06-05       Impact factor: 1.339

4.  Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China.

Authors:  Xiujuan Wu; Donghui Shen; Ting Li; Bing Zhang; Chunrong Li; Mei Mao; Jixue Zhao; Kangding Liu; Hong-Liang Zhang
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

5.  Initial Response and Outcome of Critically Ill Children With Guillain Barre' Syndrome.

Authors:  Hafez M Bazaraa; Hanaa I Rady; Shereen A Mohamed; Walaa A Rabie; Noha H ElAnwar
Journal:  Front Pediatr       Date:  2019-09-18       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.